Savara Pharmaceuticals
SVRA
$4.09
Share price
-0.49%
Change (1 day)
39.59%
Change (1 year)
Categories
Savara Pharmaceuticals (SVRA) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $36.43 M
According to Savara Pharmaceuticals's latest financial reports the company's total liabilities are $36.43 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Savara Pharmaceuticals - Total liabilities on balance sheet (from 2002 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $37.19 M | 16.23% |
| 2022-12-31 | $31.99 M | -0.31% |
| 2021-12-31 | $32.1 M | -3.78% |
| 2020-12-31 | $33.36 M | -3.31% |
| 2019-12-31 | $34.5 M | -21.7% |
| 2018-12-31 | $44.06 M | 9.3% |
| 2017-12-31 | $40.31 M | -37.79% |
| 2016-12-31 | $64.8 M | 113.69% |
| 2015-12-31 | $30.32 M | 156.11% |
| 2014-12-31 | $11.84 M | 59.12% |
| 2013-12-31 | $7.44 M | 43.68% |
| 2012-12-31 | $5.17 M | 2% |
| 2011-12-31 | $5.07 M | 181.87% |
| 2010-12-31 | $1.8 M | -23.46% |
| 2009-12-31 | $2.35 M | -50.07% |
| 2008-12-31 | $4.71 M | 34.41% |
| 2007-12-31 | $3.5 M | 41.18% |
| 2006-12-31 | $2.48 M | -92.1% |
| 2005-12-31 | $31.45 M | 2481.29% |
| 2004-12-31 | $1.21 M | 647.29% |
| 2003-12-31 | $0.16 M | -83.41% |
| 2002-12-31 | $0.98 M | 7.26% |
| 2001-12-31 | $0.91 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.72 B | 1,879.49% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $12.15 M | -66.63% | 🇺🇸 USA |